Disclosure of Financial Information

Collaboration between healthcare professionals and pharmaceutical companies has had a positive impact on the development of treatments and medicines. These partners often work hand in hand on research and education initiatives—always with the aim of benefiting patients.

With the introduction of ethical guidelines, pharmaceutical companies and healthcare professionals have strengthened the rules governing their cooperation. The public must be able to trust that such collaboration does not influence clinical decisions, and that healthcare professionals recommend, provide, or purchase treatment and services based solely on clinical evidence and professional experience.



Since 2016, member companies of EFPIA and Frumtök, along with other pharmaceutical firms, have published annual reports detailing payments made in connection with collaborations with healthcare professionals and healthcare institutions.

The European Commission has issued regulations promoting good governance within the pharmaceutical industry, agreed upon by all stakeholders